Ruben S. Escuro practices Oncology. He studied medicine at University of the Philippines College of Medicine. He over the years received 2 awards: "CMS Meaningful Use Stage 1 Certification" and "Top MD". Ruben S. Escuro, MD is a published physician. He published 2 publications, including: 'Prospective evaluation of a Candida antigen detection test for invasive candidiasis in immunocompromised adult patients with cancer.' Ruben Escuro is registered with Medicare.
NPI NUMBER | 1194777292 | |
NPPES Provider LastName | ESCURO | |
NPPES Provider FirstName | RUBEN | |
NPPES Provider ZIPCode | 440352220 | |
NPPES Provider State | OH | |
Specialty Description | Hematology/Oncology | |
Total Claim Count | 845.0 | |
Distinct Opioid Count | 4.0 | |
Opioid Claim Count | 68.0 | |
Percent Opioid Claims | 8.05 |
National Provider Identifier [NPI] | 1194777292 |
Last Name Of The Provider | ESCURO |
First Name Of The Provider | RUBEN |
View All |
![]() |
Dr. Jay Sidloski, DO
![]() |
![]() |
Dr. Belagodu Kantharaj, MD
![]() |
![]() |
Dr. Patrick Litam, MD
![]() ![]() |
![]() |
Dr. William H. Sigalove, MD
![]() |